Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers
Matthias Pauthner, Joseph P. Nkolola, Colin Havenar‐Daughton, et al.
Immunity (2018) Vol. 50, Iss. 1, pp. 241-252.e6
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Controlling timing and location in vaccines
Darrell J. Irvine, Aereas Aung, Murillo Silva
Advanced Drug Delivery Reviews (2020) Vol. 158, pp. 91-115
Open Access | Times Cited: 200
Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination
Archana V. Boopathy, Anasuya Mandal, Daniel W. Kulp, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 33, pp. 16473-16478
Open Access | Times Cited: 168
Advancing an HIV vaccine; advancing vaccinology
Dennis R. Burton
Nature reviews. Immunology (2018) Vol. 19, Iss. 2, pp. 77-78
Open Access | Times Cited: 165
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
Prabhu S. Arunachalam, Tysheena P. Charles, Vineet Joag, et al.
Nature Medicine (2020) Vol. 26, Iss. 6, pp. 932-940
Open Access | Times Cited: 145
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2234-2245
Open Access | Times Cited: 120
Ultra-accurate microbial amplicon sequencing with synthetic long reads
Benjamin J. Callahan, Dmitry O. Grinevich, Siddhartha Thakur, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
Peter B. Gilbert, Yunda Huang, Allan C. deCamp, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1924-1932
Open Access | Times Cited: 75
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Wilton B. Williams, S. Munir Alam, Gilad Ofek, et al.
Cell (2024) Vol. 187, Iss. 12, pp. 2919-2934.e20
Open Access | Times Cited: 14
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
Viktoriya Dubrovskaya, Karen Tran, Gabriel Ozorowski, et al.
Immunity (2019) Vol. 51, Iss. 5, pp. 915-929.e7
Open Access | Times Cited: 127
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
Rui Kong, Hongying Duan, Zizhang Sheng, et al.
Cell (2019) Vol. 178, Iss. 3, pp. 567-584.e19
Open Access | Times Cited: 126
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Cell Host & Microbe (2019) Vol. 26, Iss. 3, pp. 336-346.e3
Open Access | Times Cited: 107
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
Rui Kong, Hongying Duan, Zizhang Sheng, et al.
Cell (2019) Vol. 178, Iss. 3, pp. 567
Closed Access | Times Cited: 101
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson, Kshitij Wagh, Bette Korber, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 673-703
Open Access | Times Cited: 100
Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines
Bartek Nogal, Matteo Bianchi, Christopher A. Cottrell, et al.
Cell Reports (2020) Vol. 30, Iss. 11, pp. 3755-3765.e7
Open Access | Times Cited: 96
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
The Conformational States of the HIV-1 Envelope Glycoproteins
Qian Wang, Andrés Finzi, Joseph Sodroski
Trends in Microbiology (2020) Vol. 28, Iss. 8, pp. 655-667
Open Access | Times Cited: 83
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
Christopher A. Cottrell, Jelle van Schooten, Charles A. Bowman, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 8, pp. e1008753-e1008753
Open Access | Times Cited: 78
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
Aleksandar Antanasijevic, Leigh M. Sewall, Christopher A. Cottrell, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 57
Maternal immune protection against infectious diseases
Stephanie N. Langel, Maria Blasi, Sallie R. Permar
Cell Host & Microbe (2022) Vol. 30, Iss. 5, pp. 660-674
Open Access | Times Cited: 40
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates
Yi-Nan Zhang, Jennifer Paynter, Aleksandar Antanasijevic, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge
Amarendra Pegu, Sarah Lovelace, Megan Demouth, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 730
Closed Access | Times Cited: 7
Rapid Germinal Center and Antibody Responses in Non-human Primates after a Single Nanoparticle Vaccine Immunization
Colin Havenar‐Daughton, Diane G. Carnathan, Archana V. Boopathy, et al.
Cell Reports (2019) Vol. 29, Iss. 7, pp. 1756-1766.e8
Open Access | Times Cited: 54
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
Barbara K. Felber, Zhongyan Lu, Xintao Hu, et al.
Cell Reports (2020) Vol. 31, Iss. 6, pp. 107624-107624
Open Access | Times Cited: 52
Innovations in structure-based antigen design and immune monitoring for next generation vaccines
Andrew B. Ward, Ian A. Wilson
Current Opinion in Immunology (2020) Vol. 65, pp. 50-56
Open Access | Times Cited: 51
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
Per Johan Klasse, Gabriel Ozorowski, Rogier W. Sanders, et al.
Cell Host & Microbe (2020) Vol. 27, Iss. 4, pp. 507-518
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top